fbpx
June 1, 2020

Telerehabilitation May Be Effective in MS Telerehabilitation May Be Effective in MS

Telerehabilitation is safe and may offer functional benefits comparable to those of outpatient rehabilitation for patients with multiple sclerosis (MS) and impaired mobility. Telerehabilitation also saves […]
June 1, 2020

Constraint Movement Therapy May Boost Neuroplasticity in MS Constraint Movement Therapy May Boost Neuroplasticity in MS

Neuroimaging of patients with progressive multiple sclerosis (MS) shows that physical behavioral change therapy, specifically, constraint-induced movement therapy (CIMT), leads to improvement in neuroplasticity compared to […]
April 15, 2020

Antiepileptic May Counter Rivaroxaban’s Anticoagulant Effect Antiepileptic May Counter Rivaroxaban’s Anticoagulant Effect

Researchers are warning about the possible detrimental effects of combining the anti-seizure drug levetiracetam with the direct oral anticoagulant rivaroxaban (Xarelto, Bayer/Janssen). In what investigators are […]
April 14, 2020

Sodium Nitrite Disappoints in Cardiac Arrest Sodium Nitrite Disappoints in Cardiac Arrest

Among patients who had an out-of-hospital cardiac arrest, intravenous sodium nitrite given by paramedics during resuscitation did not significantly improve their chances of being admitted to […]
April 14, 2020

‘Hypercoagulation,’ Antiphospholipid Antibodies Seen in COVID-19 ‘Hypercoagulation,’ Antiphospholipid Antibodies Seen in COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s  Coronavirus Resource Center. COVID-19 infection may represent a “hypercoagulable” state, new research suggests. Researchers from […]
April 14, 2020

New Guideline to Improve Ménière’s Disease Diagnosis, Treatment New Guideline to Improve Ménière’s Disease Diagnosis, Treatment

A new clinical practice guideline from the American Academy of Otolaryngology‒Head and Neck Surgery Foundation (AAO-HNSF) is providing evidence-based recommendations for the diagnosis and treatment of […]
April 13, 2020

FDA Approves Koselugo for Pediatric Neurofibromatosis Treatment FDA Approves Koselugo for Pediatric Neurofibromatosis Treatment

The Food and Drug Administration has approved selumetinib (Koselugo) for the treatment of pediatric patients aged 2 years and older with type 1 neurofibromatosis (NF1) with […]
April 10, 2020

Dementia Experts Point to Patients’ Special Needs During COVID-19 Pandemic Dementia Experts Point to Patients’ Special Needs During COVID-19 Pandemic

(Reuters Health) – The “double hit” of dementia and the coronavirus pandemic creates an especially vulnerable group of patients and caregivers, dementia experts say. During the […]
April 9, 2020

First Case of COVID-19 Presenting as Guillain-Barré Reported First Case of COVID-19 Presenting as Guillain-Barré Reported

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Physicians in China are reporting what they believe is the first case […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0